MediWound Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, MediWound stock has a consensus rating of "Strong Buy" and an average price target of $30.17. The average 1-year stock price forecast is 116.35% higher than the current stock price, while the lowest is $22 (+57.76%) and the highest is $36 (+158.16%).

Price Target: $30.17 (+116.35%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$22	$30.17	$31	$36
Change	+57.76%	+116.35%	+122.30%	+158.16%

Analyst Ratings

The average analyst rating for MediWound stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	5	5	5	5	5	5
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Okunewitch Maxim Group	Maxim Group	Buy Maintains $30	Buy	Maintains	$30	+115.13%	Jun 2, 2026
Scott Henry Alliance Global Partners	Alliance Global Partners	Buy Maintains $25 → $22	Buy	Maintains	$25 → $22	+57.76%	May 28, 2026
Jeff Jones Oppenheimer	Oppenheimer	Buy Maintains $34 → $32	Buy	Maintains	$34 → $32	+129.47%	May 28, 2026
Swayampakula Ramakanth H.C. Wainwright	H.C. Wainwright	Buy Reiterates $14 → $36	Buy	Reiterates	$14 → $36	+158.16%	May 28, 2026
Josh Jennings TD Cowen	TD Cowen	Buy Reiterates $25	Buy	Reiterates	$25	+79.28%	May 27, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

24.13M

from 16.96M

42.26%

from 16.96M

Revenue Next Year

32.87M

from 24.13M

36.26%

from 24.13M

EPS This Year

-2.39

from -2.10

EPS Next Year

-2.22

from -2.39

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	23.76M	26.50M	18.69M	20.22M	16.96M	24.13M
Revenue Growth	9.19%	11.50%	-29.48%	8.22%	-16.14%	42.26%
Gross Profit	8.77M	13.17M	3.58M	2.63M	3.25M	5.40M
Gross Margin	36.91%	49.69%	19.15%	13.03%	19.19%	22.40%
Operating Income	-11.22M	-7.66M	-15.50M	-19.40M	-25.27M	-34.16M
Net Income	-13.55M	-19.60M	-6.72M	-30.22M	-23.88M	-29.90M
EPS	-	-	-	-	-2.10	-2.39
Free Cash Flow	-1.36M	-8.82M	-3.05M	-6.59M	-15.58M	-38.30M
No. Analysts	-	-	-	-	-	6

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	25.3M
Avg	24.1M
Low	22.5M

Revenue Growth

Revenue Growth	2026	2027	2028
High	49.3%
Avg	42.3%
Low	32.7%

EPS Forecast

EPS	2026	2027	2028
High	-2.01
Avg	-2.39
Low	-2.78

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-